Metraipolis › archive › dc_fd4d74382007

COVID-19 and Influenza Booster Vaccination Elicits Robust Antibody Responses in Patients with Primary Brain Tumors Comparable to Healthy Adults — Europe PMC PMID:41681966

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41681966
DOI
10.3390/cancers18030494
License (as archived)
solo-consultazione
Archived
2026-11-06T08:01:44.180Z
SHA-256 of the archived text
759ae28f188d650c8acbb15cf8520a243699b72a18d3d64fc69665553c0904c0
Stable URL of this page
https://metraipolis.com/documento/dc_fd4d74382007

How to cite

COVID-19 and Influenza Booster Vaccination Elicits Robust Antibody Responses in Patients with Primary Brain Tumors Comparable to Healthy Adults — Europe PMC PMID:41681966 — Europe PMC (en), https://europepmc.org/article/MED/41681966 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_fd4d74382007 (Metraipolis archive dc_fd4d74382007, sha256 759ae28f188d650c8acbb15cf8520a243699b72a18d3d64fc69665553c0904c0)
BibTeX
@misc{dcfd4d74382007,
  title = {COVID-19 and Influenza Booster Vaccination Elicits Robust Antibody Responses in Patients with Primary Brain Tumors Comparable to Healthy Adults — Europe PMC PMID:41681966},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41681966},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_fd4d74382007; sha256 759ae28f188d650c8acbb15cf8520a243699b72a18d3d64fc69665553c0904c0},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41681966. Agents can read the archived copy with the MCP tool read_document.